EC HealthcareUNHLF 72 EBITDA Margin % is 16.25% as of Sep. 2025, which is 42% below its 10-year median of 27.98. GuruFocus rates UNHLF with a GF Score™ of 72/100 and a GF Value™ of $0.35. The stock has 7 warning signs investors should review. Among 668 Healthcare Providers & Services companies, EC Healthcare ranks better than 58.23% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. EC Healthcare's EBITDA for the
six
months ended in Sep. 2025 was $40.3 Mil. EC Healthcare's Revenue for the
six
months ended in Sep. 2025 was $248.0 Mil. Therefore, EC Healthcare's EBITDA margin for the quarter that ended in Sep. 2025 was 16.25%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
EC Healthcare EBITDA Margin % Related Terms
EC Healthcare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for EC Healthcare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UNHLF vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, EC Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EC Healthcare EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EC Healthcare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where EC Healthcare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EC Healthcare (UNHLF) has a EBITDA Margin % of 16.25% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EC Healthcare and its competitors. This is 42% below median its historical median of 27.98. Over the past decade, EC Healthcare's EBITDA Margin % has ranged from 13.39 to 32.04. According to the industry distribution chart, EC Healthcare ranks #279 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 41.8%.
Is EC Healthcare's EBITDA Margin % too high?
EC Healthcare's current EBITDA Margin % of 16.25% is 42% below median its 10-year median of 27.98. Over the past 10 years, this metric has ranged from a low of 13.39 to a high of 32.04. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. EC Healthcare's value of 16.25% is 59.2% above this industry median. Based on the distribution chart, EC Healthcare ranks #279 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, EC Healthcare has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does EC Healthcare's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EC Healthcare ranks #279 out of 668 companies for EBITDA Margin %. This puts EC Healthcare in the upper half of its industry. The industry median EBITDA Margin % is 10.21. EC Healthcare's value of 16.25% is 59.2% above this benchmark. Historically, EC Healthcare's own EBITDA Margin % has ranged from 13.39 to 32.04 over the past decade. While the company's 10-year median is 27.98 vs. the industry median of 10.21, EC Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EC Healthcare's current EBITDA Margin % of 16.25% is 59.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EC Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EC Healthcare's current EBITDA Margin % is 16.25%, which is 42% below median its own 10-year median of 27.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EC Healthcare stock overvalued right now?
EC Healthcare (UNHLF) has a current EBITDA Margin % of 16.25%. The stock's GF Value™ is $0.35, compared to a current price of $0.09 — trading 75.4% below its estimated fair value. The current EBITDA Margin % is 16.25%, which is 42% below median its 10-year median of 27.98 and 59.2% above the Healthcare Providers & Services industry median of 10.21. EC Healthcare's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For EC Healthcare (UNHLF), the current EBITDA Margin % is 16.25% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EC Healthcare (UNHLF) Overvalued in 2026?
Based on GuruFocus' analysis, EC Healthcare stock appears to be undervalued.
The current stock price of $0.09 is trading 75.4% below its estimated GF Value™ of $0.35.
Key valuation signals for UNHLF:
EBITDA Margin %: 16.25% (42% below median its 10-year median of 27.98)
GF Value™: $0.35 vs. price of $0.09 (75.4% below fair value)
Industry Position: 59.2% above the Healthcare Providers & Services median (#279 of 668)
No single metric tells the full story. See the UNHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EC Healthcare is a Hong Kong-based non-hospital medical service provider. The principal activities of the group include the provision of medical services; aesthetic medical services, comprising medical aesthetics and dental services; beauty and wellness services, comprising traditional beauty, haircare, and ancillary wellness services; and the sale of skincare, healthcare, and beauty products. The group caters to its services through the operating segments of Medical, which is the key revenue generator segment and Aesthetic medical, beauty and wellness, Veterinary, and others. Geographically, the group has a business presence in Hong Kong, Macau, Mainland China, and Taiwan. It generates the majority of its revenue from Hong Kong.
72GF Score
Get the complete analysis for UNHLF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UNHLF has been successfully added to your 
